Sort Results:
List of Materials
![]() |
Changing Landscape of Drug Discovery in Industry SettingsThis lecture entitled “Changing Landscape of Drug Discovery in Industry Settings†introduces the drug discovery and development process to a class focused on a range of topics related to discovery and development of new therapeutic agents... |
Vanderbilt Center for Neuroscience Drug Discovery Vanderbilt University Presenter: P. Jeffrey Conn |
![]() |
Drug-Like Properties and Druggable TargetsA lecture discussing the concept of drug-like molecular properties, druggable targets, and chemical space. |
Brain Science Institute NeuroTranslational Drug Discovery Program Johns Hopkins University Presenter: Takashi Tsukamoto, Ph.D. |
Molecular Subtypes in Glioblastoma Multiforme: Integrated Analysis Using Agilent GeneSpring and Mass Profi ler Professional Multi-Omics SoftwareAgilent GeneSpring and Mass Profi ler Professional (MPP) software was used to perform integrated multi-omics analysis of mRNA expression, miRNA expression, protein expression, and copy number aberration (CNA) associated with glioblastoma multiforme... |
Agilent Technologies Presenter: D. Renu, P. Aggarwal, S. Cherukuri, P. Tata, V. Bhat, C. Livi, M. Rosenberg, M. Al-Gizawiy, K. Schmainda, S. Mirza |
|
![]() |
Target and Pathway InterrogationThis talk will cover key concepts and methods when attempting to study a target or pathway using low-molecular compound screening approaches. The talk will provide an overview of integrated lead finding, reverse and forward chemical genomic... |
Novartis Institutes for Biomedical Research Presenter: Douglas Auld |

